Carmichael Hill & Associates’s Elanco Animal Health ELAN Stock Holding History

Carmichael Hill & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.51K	Hold	171	–	–	﹤0.01%	696
2024 Q2	$2.47K	Hold	171	–	–	﹤0.01%	687
2024 Q1	$2.78K	Hold	171	–	–	﹤0.01%	670
2023 Q4	$2.55K	Hold	171	–	–	﹤0.01%	698
2023 Q3	$1.92K	Hold	171	–	–	﹤0.01%	703
2023 Q2	$1.72K	Hold	171	–	–	﹤0.01%	709
2023 Q1	$1.61K	Hold	171	–	–	﹤0.01%	705
2022 Q4	$2.09K	Hold	171	–	–	﹤0.01%	684
2022 Q3	$2K	Hold	171	–	–	﹤0.01%	738
2022 Q2	$3K	Hold	171	–	–	﹤0.01%	698
2022 Q1	$4K	Hold	171	–	–	﹤0.01%	699
2021 Q4	$5K	Hold	171	–	–	﹤0.01%	700
2021 Q3	$5K	Hold	171	–	–	﹤0.01%	689
2021 Q2	$6K	Hold	171	–	–	﹤0.01%	653
2021 Q1	$5K	Hold	171	–	–	﹤0.01%	651
2020 Q4	$5K	Hold	171	–	–	﹤0.01%	622
2020 Q3	$5K	Hold	171	–	–	﹤0.01%	586
2020 Q2	$4K	Hold	171	–	–	﹤0.01%	566
2020 Q1	$4K	Hold	171	–	–	﹤0.01%	547
2019 Q4	$5K	Buy	+171	New	+$4.65K	﹤0.01%	552

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Carmichael Hill & Associates's ELAN Position: Q3 2024 in Review

Carmichael Hill & Associates held its Elanco Animal Health (ELAN) position steady in Q3 2024 at 171 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Carmichael Hill & Associates first reported a position in ELAN in Q4 2019 and has held it in 20 quarters since. The position peaked at $6K in Q2 2021. 388 funds tracked by Wall St. Rank hold ELAN as of Q3 2024.

Carmichael Hill & Associates held 171 shares of Elanco Animal Health worth $2.51K as of Q3 2024.
Carmichael Hill & Associates left its Elanco Animal Health share count unchanged in Q3 2024.
Elanco Animal Health made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #696 holding.
Carmichael Hill & Associates first reported a position in Elanco Animal Health in Q4 2019 and has held it in 20 quarters since.
Carmichael Hill & Associates's Elanco Animal Health position peaked at $6K in Q2 2021.
388 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.